FDA-cleared BVA™ technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care. OAK RIDGE, Tenn. – Daxor Corporation (Nasdaq: DXR), the global leader …
Copyright © CB Herald. 2026
